Deals, Partnering

Genzyme and Veracyte announce global co-promotion agreement to deliver personalized solution for thyroid patients

Posted on 20 January 2012

Tags: , ,

Genzyme and Veracyte announced a global co-promotion partnership to provide a comprehensive solution for thyroid patients.

The arrangement will give patients worldwide increased access to an advanced personalized medicine solution for improved diagnosis of thyroid nodules, and the potential to significantly reduce the number of unnecessary thyroidectomies. 

Under terms of the agreement, Genzyme will market and promote Veracyte’s Afirma® Thyroid FNA Analysis, an innovative and novel approach for improved thyroid nodule diagnosis, in the United States and, subsequently, in global markets. Financial terms of the deal were not disclosed.

“This partnership is a strong fit for both companies and underscores Genzyme’s commitment to improving the quality of care for patients with suspected or diagnosed thyroid cancer,” said Genzyme’s Head of Rare Diseases, Rogerio Vivaldi, M.D. “Together, our products offer patients and physicians a powerful personalized medicine solution for the diagnosis and treatment of thyroid cancer, addressing an unmet need in the community and improving patient outcomes.”

“We are delighted to join forces with Genzyme,” said Bonnie Anderson, Veracyte’s Cofounder and CEO. “This powerful partnership will enable us to utilize Genzyme’s specialized endocrinology sales force and marketing infrastructure to commercialize our Afirma Thyroid FNA Analysis more quickly in the U.S. and globally. In addition to benefitting patients, our solution will improve the cost-effectiveness of thyroid nodule diagnosis worldwide.”

A recent economic impact study, published in the Journal of Clinical Endocrinology & Metabolism, concluded that routine use of the Afirma Gene Expression Classifier in the U.S. would prevent tens of thousands of avoidable surgeries each year and would provide more than $600 million in direct medical savings over 5 years.

 

Buy the on-demand report Partnering Agreements with Genzyme

See additional deal data at Current Agreements (subscription required)

Print Friendly, PDF & Email

Leave a Reply